Kolexia
Hanaire Helene
Endocrinologie
Hôpital Rangueil
Toulouse, France
261 Activités
10 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète Diabète de type 1 Diabète de type 2 Hypoglycémie Hyperglycémie Obésité Apnée Insulinorésistance Obésité morbide

Industries

Abbott
21 collaboration(s)
Dernière en 2023
Lilly
19 collaboration(s)
Dernière en 2023
Sanofi
17 collaboration(s)
Dernière en 2023
Medtronic
14 collaboration(s)
Dernière en 2023

Dernières activités

Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop Modes.
Diabetes technology & therapeutics   07 mars 2024
The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes.
Diabetes, obesity & metabolism   22 janvier 2024
RADIANT: Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)
Essai Clinique (Insulet Corporation)   04 décembre 2023
Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.
Diabetes, obesity & metabolism   03 novembre 2023
SP12: Observational Study of the Use of DBLG1 System in Real Life
Essai Clinique (Diabeloop)   06 septembre 2023
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes
ISSHP 2022 Abstracts   01 septembre 2023
BETTER: Interventional Before/After Study of the Effect of the DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump on Glucose Control of Patients With Type 1 Diabetes in France. The BETTER Trial
Essai Clinique (Diabeloop)   13 juin 2023
SFDT1 - Webinaire patients - Thématique boucle fermée
Youtube @ Communauté SFDT1   22 février 2023
Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial.
Diabetes & metabolism   11 février 2023
Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Diabetes care   05 décembre 2022